Tiger Eye Capital LLC Guardant Health, Inc. Transaction History

Tiger Eye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$59.49 - $82.78 $2.56 Million - $3.56 Million	-42,955 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$62.59 - $110.3 $2.03 Million - $3.58 Million	-32,490 Reduced 43.06%	42,955 $2.74 Million
Q2 2019 Aug 14, 2019	BUY	$63.94 - $91.11 $3.19 Million - $4.55 Million	49,945 Added 195.86%	75,445 $6.51 Million
Q1 2019 May 15, 2019	BUY	$34.3 - $97.98 $874,649 - $2.5 Million	25,500 New	25,500 $1.96 Million

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Tiger Eye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Tiger Eye Capital LLC with notifications on news.